Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc

Bullboard Posts

Comment by Gekkoinon Mar 18, 2015 3:03pm

61 Views

Post# 23535150

RE:MD&A's don't lie... numbers are pretty scary... lol

This is how a bunch of incompetent's dance on and around the letter of securities law and the rules of the Exchanges.... (or lack there of)
Smoke and mirrors... big salaries and compensation packages....zero performance... who cares they say... they get paid no matter what they do or don't do.....

Bullboard Posts

Corus reports Q1 profit drop in the face of falling revenue